The global Metagenomic Sequencing Market size is projected to reach a CAGR of 19.1% from 2023-2030.
"Metagenomics" is the two words "meta" and "genomics". So, genomics is obtaining the DNA sequence, but meta implies that we're doing it of many organisms together. And metagenomics is usually used when we are studying microbial communities where we can't separate one microbe from another. Like there may be two bacteria that grow together, and so when you take the DNA sequence, you're getting the DNA sequence of two bacteria together.
Get Free Sample Report@ https://www.delvens.com/get-free-sample/metagenomic-sequencing-market
Growth in the Metagenomic Sequencing Market can largely be attributed to factors such as Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields.
Recent Developments
· In January 2021, Illumina, Inc. (US) collaborated with Helix to increase national surveillance infrastructure in the US to track the emergence and prevalence of novel strains of SARS-CoV-2 with support from the CDC.
· In June 2020, Illumina (US) acquired BlueBee, a cloud-based software company that provides genomic analysis solutions for research and clinical customers. Through this acquisition, Illumina enhanced its capabilities to analyze and interpret the data produced by its sequencing systems.
Prominent Players
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- QIAGEN N.V.
- PerkinElmer
- Oxford Nanopore Technologies Ltd.
- BGI Group
- Macrogen Inc.
- GENEWIZ
- Eurofins Scientific
- Novogene Corporation
For More Inquiry@ https://www.delvens.com/Inquire-before-buying/metagenomic-sequencing-market
North America to Dominate the Market
- North America accounted for the largest share of the metagenomic sequencing market in 2021. Factors such as the increasing applications of metagenomics in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions are driving the growth of the metagenomic sequencing market in North America.
- The market in the Asia Pacific is expected to register the highest growth rate during the forecast period, primarily due to the increasing financial support from public as well as private agencies, the increasing number of NGS-based research projects, increasing awareness about precision medicine, and the rising prevalence of chronic diseases.
Metagenomic Sequencing Market Segmentation:
On the basis of product and services
· Reagents & Consumables
· Instruments
· Services
· Analysis & Data Interpretation Solutions
On the basis of workflow
· Sample Processing & Library Preparation
· Sequencing
· Data Processing & Analysis
On the basis technology
· Shotgun Metagenomic Sequencing
· 16S rRNA Sequencing
· Metatranscriptomics
· Whole-genome Sequencing & De Novo Assembly
On the basis of application
· Drug Discovery
· Clinical Diagnostics
· Soil Microbiome Applications
· Industrial applications
· Ecological and Environmental Applications
· Veterinary Applications
· Other Applications
Based on region:
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
Get Detailed Report: https://www.delvens.com/report/metagenomic-sequencing-market
Frequently Asked Questions
· What are the years considered to study Metagenomic Sequencing Market?
· What is the compound annual growth rate (CAGR) of the Metagenomic Sequencing Market?
· Which region holds the largest market share in Metagenomic Sequencing Market?
· Which region is growing with the highest CAGR during the forecast period 2023-2030?
· Who are the major players in Metagenomic Sequencing Market?
In addition to the market data for Metagenomic Sequencing Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirement.
More Related Reports:
Metagenomic Sequencing Market
Nucleic Acid Testing (NAT) Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
Comments
0 comment